Novel Oral Anticoagulant Fast Tracked for Patients With ESRD and Atrial Fibrillation
Tecarfarin is a novel oral vitamin K antagonist with a similar mechanism of action to warfarin, though it is metabolized differently.
Diagnosis & Disease Information
Apixaban Bests Rivaroxaban in “Emulated” Trial of Patients With Afib and VHD
Apixaban and rivaroxaban are both factor Xa inhibitors.
USPSTF Issues Final Recommendations on Statin Use for Primary Prevention of CVD
These recommendations apply only to individuals without a history of CVD and who are not already taking statins.
Novel Anticoagulant Therapy for Patients With ESRD Gets Fast Track Status
MK-2060 is an investigational monoclonal antibody designed to inhibit the activation of Factor XI and its ability to activate downstream proteins.
Sotagliflozin Under Review for Heart Failure Treatment
Sotagliflozin is an investigational dual sodium-glucose co-transporter types 1 and 2 (SGLT1, SGLT2) inhibitor.
Novel 12-LOX Inhibitor Fast Tracked for Heparin-Induced Thrombocytopenia
VLX-1005 is a first-in-class, selective small molecule inhibitor of 12-lipoxygenase, a key target within the arachidonic acid pathway.
Novel Antithrombotic Fast Tracked for Noncardioembolic Ischemic Stroke
The Company is currently evaluating asundexian as monotherapy or in combination with antiplatelet therapy in the PACIFIC phase 2 clinical trial program.
Xarelto Approved to Treat and Prevent Blood Clots in Pediatric Patients
A new oral suspension formulation of Xarelto has also been approved by the FDA.
FDA Clears Neuromuscular Stimulation Device for Venous Insufficiency and Ischemia
The geko device is designed to stimulate the common peroneal nerve.
High Temperature Exposure Prompts Recall of Anticoagulant Med
Exposure to higher temperatures may have significantly impacted the efficacy of the recalled product.
- Loading...
Loading...
Next post in News
Loading... 
Loading...